A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis

Jianhua Lia The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USAView further author information

Cassie Shu Zhua The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USAView further author information

Li Heb Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAView further author information

Xiaoling Qianga The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA;c Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY, USAView further author information

Weiqiang Chena The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA;c Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY, USAView further author information

Haichao Wanga The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA;c Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY, USACorrespondence[email protected]

https://orcid.org/0000-0002-0211-9000 View further author information

A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date